Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations, part II.

Autor: Hamilton CA; Gynecologic Oncology Section, Women's Services and the Ochsner Cancer Institute, Ochsner Health, New Orleans, LA, United States of America. Electronic address: chad.hamilton@ochsner.org., Pothuri B; Department of Obstetrics and Gynecology, NYU School of Medicine, New York City, NY, United States of America., Arend RC; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL, United States of America., Backes FJ; Division of Gynecologic Oncology, Ohio State University and James Cancer Hospital, Columbus, OH, United States of America., Gehrig PA; Professor and Chief, Division of Gynecologic Oncology, University of North Carolina, Chapel Hill, NC, United States of America., Soliman PT; Department of Gynecologic Oncology and Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Thompson JS; Division of Radiation Oncology, Stephenson Cancer Center, University of Oklahoma, Oklahoma City, OK, United States of America., Urban RR; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Washington School of Medicine, Seattle, WA, United States of America., Burke WM; Department of Obstetrics, Gynecology and Reproductive Medicine, Stony Brook University Cancer Center, Stony Brook, NY, United States of America.
Jazyk: angličtina
Zdroj: Gynecologic oncology [Gynecol Oncol] 2021 Mar; Vol. 160 (3), pp. 827-834. Date of Electronic Publication: 2021 Jan 13.
DOI: 10.1016/j.ygyno.2020.12.024
Abstrakt: In 2014, the Society of Gynecologic Oncology's Clinical Practice Committee published a clinical update reviewing the treatment of women with endometrial cancer. At that time, there had been significant advances in the diagnosis, work-up, surgical management, and available treatment options allowing for more optimal care of affected women. This manuscript, Part II in a two-part series, includes specific recommendations on treatment of recurrent disease, post treatment surveillance and survivorship, considerations for younger women, and special situations. Part I covered histopathology and molecular pathology, risk factors, presentation and diagnostic approach, surgical approach and adjuvant therapy.
Competing Interests: Declaration of Competing Interest The authors of this paper report that they have no conflicts of interest related to any of the content of this manuscript.
(Copyright © 2020 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: